Avorna: Side Effects & Dosing

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Side Effects Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Dutasteride

Indications/Uses

Monotherapy or in combination w/ tamsulosin for treatment & control of symptomatic benign prostatic hyperplasia (BPH) in men w/ enlarged prostate to improve symptoms, reduce risk of acute urinary retention & need for BPH-related surgery.

Click to view Avorna detailed prescribing information

Dosage/Direction for Use

Adult male (including elderly) 0.5 mg once daily.

Click to view Avorna detailed prescribing information

Overdosage

View Avorna overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food: Swallow whole, do not chew/open.

Contraindications

Hypersensitivity to dutasteride, other 5α-reductase inhibitors, soya or peanut. Severe hepatic impairment. Pregnancy. Women, childn & adolescents.

Click to view Avorna detailed prescribing information

Special Precautions

Rule out other urological diseases prior to treatment. Changes in breast tissue eg, lumps or nipple discharge; male breast cancer. Monitor for obstructive uropathy in patients w/ large residual urinary vol &/or severely diminished urinary flow. Perform digital rectal exam & serum PSA level for prostate cancer detection. Avoid donating blood until at least 6 mth after last dose. Combination therapy w/ α-blocker. Mild to moderate hepatic impairment. Lactation. Women, childn & adolescents must avoid contact w/ leaking cap.

Click to view Avorna detailed prescribing information

Use In Pregnancy & Lactation

Click to view Avorna detailed prescribing information

Adverse Reactions

Impotence, decreased libido, breast & ejaculation disorders.

Drug Interactions

Increased blood conc & decreased clearance w/ CYP3A4 inhibitors eg, verapamil, diltiazem.

Click to view Avorna detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Avorna detailed prescribing information

Storage

View Avorna storage conditions for details to ensure optimal shelf-life.

Description

View Avorna description for details of the chemical structure and excipients (inactive components).

Action

View Avorna mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Drugs for Bladder & Prostate Disorders

ATC Classification

G04CB02 - dutasteride ; Belongs to the class of testosterone-5-alpha reductase inhibitors. Used in the treatment of benign prostatic hypertrophy.

Regulatory Classification

Presentation/Packing

Form

Avorna softcap 0.5 mg

Packing/Price

3 × 10's

Avorna

dutasteride

Manufacturer:

Pharmaniaga Marketing

Distributor:

Pharmaniaga Logistics